This document summarizes the use of endobronchial high dose rate brachytherapy (EHDR) on intubated lung cancer patients. It describes the EHDR procedure, which involves bronchoscopy, catheter placement across the tumor, imaging, planning, and treatment delivery. Three case studies are presented, where intubated patients with lung cancers received 2-4 fractions of EHDR over 1-2 weeks. All three patients achieved the endpoint of successful extubation after treatment, with average oxygen saturation levels maintained during treatment. The document concludes that EHDR is a safe option for intubated lung cancer patients with airway obstruction and can effectively lead to extubation.